TANG CAPITAL PARTNERS LP 13D and 13G filings for Kinnate Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | Kinnate Biopharma Inc. KNTE | TANG CAPITAL PARTNERS LP | 2,601,647 5.500% | -364,068 (-12.28%) | Filing |
| 2023-11-27 4:47 pm Purchase | 2023-11-15 | 13G | Kinnate Biopharma Inc. KNTE | TANG CAPITAL PARTNERS LP | 2,965,715 6.300% | 2,965,715 (New Position) | Filing |